These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy. Nitahara-Kasahara Y; Nakayama S; Kimura K; Yamaguchi S; Kakiuchi Y; Nito C; Hayashi M; Nakaishi T; Ueda Y; Okada T Stem Cell Res Ther; 2023 Apr; 14(1):108. PubMed ID: 37106393 [TBL] [Abstract][Full Text] [Related]
23. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice. Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154 [TBL] [Abstract][Full Text] [Related]
24. Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy. García-Castañeda M; Michelucci A; Zhao N; Malik S; Dirksen RT J Gen Physiol; 2022 Sep; 154(9):. PubMed ID: 35939054 [TBL] [Abstract][Full Text] [Related]
25. Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age-related muscle wasting. Zhang P; He J; Wang F; Gong J; Wang L; Wu Q; Li W; Liu H; Wang J; Zhang K; Li M; Huang X; Pu C; Li Y; Jiang F; Wang F; Min J; Chen X J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):557-573. PubMed ID: 30884219 [TBL] [Abstract][Full Text] [Related]
26. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains. van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942 [TBL] [Abstract][Full Text] [Related]
27. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways. Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617 [TBL] [Abstract][Full Text] [Related]
28. Lipocalin 2 Influences Bone and Muscle Phenotype in the Ponzetti M; Ucci A; Maurizi A; Giacchi L; Teti A; Rucci N Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055145 [TBL] [Abstract][Full Text] [Related]
29. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Wehling-Henricks M; Sokolow S; Lee JJ; Myung KH; Villalta SA; Tidball JG Hum Mol Genet; 2008 Aug; 17(15):2280-92. PubMed ID: 18430716 [TBL] [Abstract][Full Text] [Related]
30. Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy. Dubuisson N; Davis-López de Carrizosa MA; Versele R; Selvais CM; Noel L; Van den Bergh PYD; Brichard SM; Abou-Samra M Front Immunol; 2022; 13():1049076. PubMed ID: 36569900 [TBL] [Abstract][Full Text] [Related]